{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:10:08Z","timestamp":1792804208686,"version":"4.5.0"},"reference-count":32,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12,1]]},"DOI":"10.1210\/jc.2009-1252","type":"journal-article","created":{"date-parts":[[2009,12,3]],"date-time":"2009-12-03T15:38:27Z","timestamp":1259854707000},"page":"4984-4991","source":"Crossref","is-referenced-by-count":26,"title":["Prevention of Relapse of Graves\u2019 Disease by Treatment with an Intrathyroid Injection of Dexamethasone"],"prefix":"10.1210","volume":"94","author":[{"given":"Xiao-Ming","family":"Mao","sequence":"first","affiliation":[{"name":"Departments of Endocrinology (X.-M.M., H.-Q.L., Q.L., D.-M.L., X.-J.X., G.-P.Y., P.Z., X.-H.X., J.-D.W.), Affiliated Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qin","family":"Li","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (X.-M.M., H.-Q.L., Q.L., D.-M.L., X.-J.X., G.-P.Y., P.Z., X.-H.X., J.-D.W.), Affiliated Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (X.-M.M., H.-Q.L., Q.L., D.-M.L., X.-J.X., G.-P.Y., P.Z., X.-H.X., J.-D.W.), Affiliated Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Mei","family":"Li","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (X.-M.M., H.-Q.L., Q.L., D.-M.L., X.-J.X., G.-P.Y., P.Z., X.-H.X., J.-D.W.), Affiliated Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Xie","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (X.-M.M., H.-Q.L., Q.L., D.-M.L., X.-J.X., G.-P.Y., P.Z., X.-H.X., J.-D.W.), Affiliated Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Yin","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (X.-M.M., H.-Q.L., Q.L., D.-M.L., X.-J.X., G.-P.Y., P.Z., X.-H.X., J.-D.W.), Affiliated Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (X.-M.M., H.-Q.L., Q.L., D.-M.L., X.-J.X., G.-P.Y., P.Z., X.-H.X., J.-D.W.), Affiliated Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Hong","family":"Xu","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (X.-M.M., H.-Q.L., Q.L., D.-M.L., X.-J.X., G.-P.Y., P.Z., X.-H.X., J.-D.W.), Affiliated Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Dan","family":"Wu","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (X.-M.M., H.-Q.L., Q.L., D.-M.L., X.-J.X., G.-P.Y., P.Z., X.-H.X., J.-D.W.), Affiliated Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Wang","family":"Chen","sequence":"additional","affiliation":[{"name":"Ultrasonography (S.-W.C.), Affiliated Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Kui","family":"Wang","sequence":"additional","affiliation":[{"name":"Central Laboratory (S.-K.W.), Affiliated Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113472385600_R1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s002680010167","article-title":"Management of hyperthyroidism due to Graves\u2019 and nodular disease.","volume":"24","author":"Okamoto","year":"2000","journal-title":"World J Surg"},{"key":"key\n\t\t\t\t2019041113472385600_R2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.1.01993","article-title":"A systematic review of drug therapy for Graves\u2019 hyperthyroidism.","volume":"153","author":"Abraham","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113472385600_R3","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves\u2019 disease.","volume":"343","author":"Weetman","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472385600_R4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.0.1470583","article-title":"Graves\u2019 disease: drug regimens and predictors of outcome.","volume":"147","author":"Nedrebo","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113472385600_R5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0002-9440(10)64171-5","article-title":"Expression of IP-10\/CXCL10 and MIG\/CXCL9 in the thyroid and increased levels of IP-10\/CXCL10 in the serum of patients with recent-onset Graves\u2019 disease.","volume":"161","author":"Romagnani","year":"2002","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t2019041113472385600_R6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0019","article-title":"Changes in expression of T-helper (Th)1- and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves\u2019 disease.","volume":"156","author":"Inukai","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113472385600_R7","first-page":"776","article-title":"Relationship between disease duration and predominant orbital T cell subset in Graves\u2019 ophthalmopathy.","volume":"85","author":"Aniszewski","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113472385600_R8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/jc.2005-1689","article-title":"Interferon-\u03b3 inducible \u03b1-chemokine CXCL10 involvement in Graves\u2019 ophthalmopathy: modulation by peroxisome proliferator-activated receptor-\u03b3 agonists.","volume":"91","author":"Antonelli","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113472385600_R9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF03345272","article-title":"New understanding of the role of cytokines in the pathogenesis of Graves\u2019 ophthalmopathy.","volume":"27","author":"Ajjan","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113472385600_R10","first-page":"911","article-title":"CD4+ T cells and the Th1\/Th2 imbalance are implicated in the pathogenesis of Graves\u2019 ophthalmopathy.","volume":"17","author":"Xia","year":"2006","journal-title":"Int J Mol Med"},{"key":"key\n\t\t\t\t2019041113472385600_R11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000309924","article-title":"Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves\u2019 ophthalmopathy.","volume":"197","author":"Wiersinga","year":"1988","journal-title":"Ophthalmologica"},{"key":"key\n\t\t\t\t2019041113472385600_R12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/02713680601186698","article-title":"The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy.","volume":"32","author":"Lacka","year":"2007","journal-title":"Curr Eye Res"},{"key":"key\n\t\t\t\t2019041113472385600_R13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1742-1241.2006.01004.x","article-title":"Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves\u2019 ophthalmopathy.","volume":"61","author":"Aktaran","year":"2007","journal-title":"Int J Clin Pract"},{"key":"key\n\t\t\t\t2019041113472385600_R14","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","article-title":"Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves\u2019 orbitopathy.","volume":"90","author":"Kahaly","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113472385600_R15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-2265.2003.01861.x","article-title":"Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves\u2019 ophthalmopathy receiving corticosteroid therapy.","volume":"59","author":"De Bellis","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113472385600_R16","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2265.1983.tb00040.x","article-title":"Effect of the combination of dexamethasone and sodium ipodate on serum thyroid hormones in Graves\u2019 disease.","volume":"19","author":"Arteaga","year":"1983","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113472385600_R17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-2007-1010747","article-title":"Serum free thyroid hormones are decreased by betamethasone treatment in Graves\u2019 disease.","volume":"20","author":"Gamstedt","year":"1988","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041113472385600_R18","first-page":"261","article-title":"Remission of Graves\u2019 disease with hyperthyroidism by a combination of glucocorticoids and antithyroid drugs.","volume":"83","author":"Peter","year":"1991","journal-title":"J Natl Med Assoc"},{"key":"key\n\t\t\t\t2019041113472385600_R19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2265.2000.00939.x","article-title":"Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort.","volume":"52","author":"Barre\u0300re","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113472385600_R20","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","article-title":"Clinical practice. Graves\u2019 disease.","volume":"358","author":"Brent","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472385600_R21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/eje.0.1420117","article-title":"Medical therapy of Graves\u2019 disease: effect on remission rates of methimazole alone and in combination with triiodothyronine.","volume":"142","author":"Raber","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113472385600_R22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00108-003-0876-x","article-title":"Medikamentose behandliung der immunehyperthreose (typ morbus Basedow) patientselektion, langzeitverlauf und rezidivprophylaxe.","volume":"44","author":"Quadbeck","year":"2003","journal-title":"Internist"},{"key":"key\n\t\t\t\t2019041113472385600_R23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2265.1998.00554.x","article-title":"Is there a methimazole dose effect on remission rate in Graves\u2019 disease? Results from a longterm prospective study.","volume":"49","author":"Benker","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113472385600_R24","first-page":"814","article-title":"Effect of methimazole, with or without L-thyroxine, on remission rates in Graves\u2019 disease.","volume":"83","author":"Rittmaster","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113472385600_R25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/1381612013397898","article-title":"The immunomodulatory effects of anti-thyroid drugs are mediated via actions on thyroid cells, affecting thyrocyte-immunocyte signalling: a review.","volume":"7","author":"Volpe\u0301","year":"2001","journal-title":"Curr Pharm Des"},{"key":"key\n\t\t\t\t2019041113472385600_R26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2265.1986.tb03590.x","article-title":"The immunosuppressive effect of methimazole on cell-mediated immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals.","volume":"25","author":"Balazs","year":"1986","journal-title":"Clin Endocrinol Oxf"},{"key":"key\n\t\t\t\t2019041113472385600_R27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs.","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113472385600_R28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/thy.2006.16.295","article-title":"Serum thyrotropin receptor antibodies concentrations in patients with Graves\u2019 disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and\/or thyroid response modify during the observation period.","volume":"16","author":"Carella","year":"2006","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113472385600_R29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.K05-121","article-title":"TSH receptor antibody measurements and prediction of remission in Graves\u2019 disease patients treated with minimum maintenance doses of antithyroid drugs.","volume":"53","author":"Okamoto","year":"2006","journal-title":"Endocr J"},{"key":"key\n\t\t\t\t2019041113472385600_R30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archinte.1988.00380030132023","article-title":"Graves\u2019 disease. Influence of age on clinical findings.","volume":"148","author":"Nordyke","year":"1988","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113472385600_R31","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1532-5415.1989.tb07279.x","article-title":"Age-related changes of thyroid function and immunologic abnormalities in patients with hyperthyroidism due to Graves\u2019 disease.","volume":"37","author":"Aizawa","year":"1989","journal-title":"J Am Geriatr Soc"},{"key":"key\n\t\t\t\t2019041113472385600_R32","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/105072502321085225","article-title":"Relapse of Graves\u2019 disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.","volume":"12","author":"Hoermann","year":"2002","journal-title":"Thyroid"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/12\/4984\/11059899\/jcem4984.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T02:45:13Z","timestamp":1558665913000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/12\/4984\/2597062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,1]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-1252","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1383977.856078","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,1]]}}}